Insights into cisplatin-induced neurotoxicity and mitochondrial dysfunction in Caenorhabditis elegans
Cisplatin is the most common drug in first-line chemotherapy against solid tumors. We and others have previously used the nematode Caenorhabditis elegans to identify genetic factors influencing the sensitivity and resistance to cisplatin. In this study, we used C. elegans to explore cisplatin effect...
Saved in:
Main Authors: | Carmen Martínez-Fernández (Author), Milana Bergamino (Author), Alfonso Schiavi (Author), David Brena (Author), Natascia Ventura (Author), Sebastian Honnen (Author), Alberto Villanueva (Author), Ernest Nadal (Author), Julián Cerón (Author) |
---|---|
Format: | Book |
Published: |
The Company of Biologists,
2022-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Genetic and cellular sensitivity of Caenorhabditis elegans to the chemotherapeutic agent cisplatin
by: Francisco Javier García-Rodríguez, et al.
Published: (2018) -
Caenorhabditis elegans for research on cancer hallmarks
by: Julián Cerón
Published: (2023) -
TDP-43 promotes tau accumulation and selective neurotoxicity in bigenic Caenorhabditis elegans
by: Caitlin S. Latimer, et al.
Published: (2022) -
Role of Presenilin in Mitochondrial Oxidative Stress and Neurodegeneration in Caenorhabditis elegans
by: Shaarika Sarasija, et al.
Published: (2018) -
Network pharmacology-based mechanism analysis of dauricine on the alleviating Aβ-induced neurotoxicity in Caenorhabditis elegans
by: Ranran Zhang, et al.
Published: (2024)